Utilizza questo identificativo per citare o creare un link a questo documento: http://elea.unisa.it/xmlui/handle/10556/4615
Record completo di tutti i metadati
Campo DCValoreLingua
dcterms.contributor.authorDinoto, Ettore-
dcterms.contributor.authorPecoraro, Felice-
dcterms.contributor.authorMirabella, Domenico-
dcterms.contributor.authorFerlito, Francesca-
dcterms.contributor.authorFarina, Arduino-
dcterms.contributor.authorLo Biundo, Nicola-
dcterms.contributor.authorOrlando-Conti, Pietro-
dc.date.accessioned2020-07-01T10:44:19Z-
dc.date.available2020-07-01T10:44:19Z-
dcterms.date.issued2020-
dcterms.identifier.citationDinoto E, Pecoraro F, Mirabella D, Ferlito F, Farina A, Lo Biundo N, Orlando-Conti P, Bajardi G. A single-center experience on below-the-knee endovascular treatment in diabetic patients. Translational Medicine @ UniSa 2020, 21(6): 21-23.it_IT
dcterms.identifier.issn2239-9747it_IT
dcterms.identifier.urihttp://www.translationalmedicine.unisa.it/indexit_IT
dcterms.identifier.urihttp://elea.unisa.it:8080/xmlui/handle/10556/4615-
dcterms.identifier.urihttp://dx.doi.org/10.14273/unisa-2807-
dc.description.abstractDiabetic ulceration of the foot is a major global medical, social and economic problem and is the most frequent end-point of diabetic complications. A retrospective analysis from February 2017 to May 2019 of diabetic patients presenting below-the-knee artery disease (PAD) was carried out. Only patients treated with endovascular techniques as first choice treatment were evaluated. Outcome measured was perioperative mortality and morbidity. Freedom from occlusion, secondary patency and amputation rate were all registered. Additional maneuvers including stenting or angioplasty with drug eluting balloon (DEB) were reported. A total of 167 (101 male/66 female) patients with a mean age of 71 years were included in the study. A Rutherford 3, 4, 5 and 6 categories were reported in 5, 7, 110 and 45 patients, respectively. No perioperative mortality was reported. Morbidity occurred in 4 (4.4%) cases and consisted of pseudoaneurysm. Additional stenting during first procedure was required in 7 (4%) patients, drug eluting balloon was needed in 56 (33%) patients. At 1-year follow-up, estimated freedom from occlusion and secondary patency was 70% and 80% respectively. Major amputation rate was 2.4%, minor amputation rate was 41.9%. In our experience, extreme revascularization in search of distal direct flow reduce the rate of amputations with an increase in ulcer healing. New materials and techniques such as drug eluting technology, used properly, can improve outcome.it_IT
dcterms.format.extentP. 21-23it_IT
dc.language.isoenit_IT
dcterms.sourceUniSa. Sistema Bibliotecario di Ateneoit_IT
dcterms.subjectDiabetic footit_IT
dcterms.subjectUlcerit_IT
dcterms.subjectEndovascular surgeryit_IT
dcterms.subjectBalloon angioplastyit_IT
dcterms.titleA single-center experience on below-the-knee endovascular treatment in diabetic patientsit_IT
dcterms.typeArticleit_IT
È visualizzato nelle collezioni:Translational Medicine @ UniSa. Volume 21 (jan.-apr. 2020)

File in questo documento:
Non ci sono file allegati a questo documento


Tutti i documenti archiviati in DSpace sono protetti da copyright. Tutti i diritti riservati.